← All Centene CORP filings

Centene CORP DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NYSE
CNC
Centene CORP
DEF: Centene Navigates 2025 Challenges, Eyes 40%+ EPS Growth in 2026
Centene Corporation faced significant disruption in 2025 with a GAAP diluted loss per share of $(13.53) and adjusted diluted EPS of $2.08, but anticipates over 40% growth in 2026, targeting adjusted diluted EPS exceeding $3.00.
NYSE
CNC
Centene CORP
DEFA14A: Centene Corporation Files Definitive Additional Proxy Materials
Centene Corporation has filed definitive additional materials related to its proxy statement with the Securities and Exchange Commission.
NYSE
CNC
Centene CORP
DEF: Centene Aims for Continued Growth After 'Capstone' 2024, Focuses on Medicaid, Medicare, and Marketplace
Centene reports strong 2024 financial results and outlines strategic priorities for 2025, focusing on Medicaid, Medicare, and the Health Insurance Marketplace.
NYSE
CNC
Centene CORP
DEFA14A: Centene Corporation Announces Retirement of James E. Murray
James E. Murray has retired from Centene Corporation, effective March 29, 2024, consistent with his previously announced intention.
NYSE
CNC
Centene CORP
DEFA14A: Centene Corporation Files Definitive Additional Proxy Material
Centene Corporation has filed definitive additional proxy materials with the SEC.
NYSE
CNC
Centene CORP
DEF 14A: Centene Corporation Outlines Strategy for Growth and Sustainability in 2024 Proxy Statement
Centene Corporation's 2024 proxy statement highlights the company's strategic advancements, financial performance, and commitment to sustainability and corporate governance.